Incomplete Total Body Protein Recovery in Adolescent Patients With Anorexia Nervosa

November 2, 2017 updated by: Dr. Verena Haas, Charite University, Berlin, Germany
The study aimed to assess protein accretion during weight gain in adolescent patients with Anorexia nervosa

Study Overview

Status

Completed

Conditions

Detailed Description

Background: Bone health and growth during adolescence require adequate Total Body Protein (TBPr). Re-nutrition for patients with anorexia nervosa (AN) should aim to normalize body composition, i.e. recovery of fat mass and TBPr.

Objective: The study intended to analyze predictors of protein status, including exercise status, in adolescents with AN, and to investigate whether weight gain would replete body protein deficits.

Methods: The investigators assessed TBPr in a longitudinal, observational study as height-adjusted nitrogen index (NI) using in-vivo neutron activation analysis in adolescents with AN at the commencement of refeeding (T0), as well as seven months thereafter (T1), and in age-matched normal weight controls. Lean tissue and fat mass were assessed with Dual-Energy X-Ray Absorptiometry (DXA). BMI, BMI-SDS and lean tissue mass were tested as predictors of protein status using Receiver Operating Characteristic (ROC) analysis.

Study Type

Observational

Enrollment (Actual)

154

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

At baseline assessment, ten patients had primary amenorrhea and 87 girls secondary amenorrhea. Six girls were not amenorrhoeic but were taking oral contraceptives or had lost more than 20% of their weight and fulfilled the remaining diagnostic criteria for AN. The mean duration of the eating disorder at the time of testing was 15 ± 12 months, ranging from 3 to 60 months and estimated premorbid BMI of the AN patients was 20.4 ± 2.9 (13.5 - 28.7 kg/m2; data available for 98 patients). Before admission, the patients (n = 97) had lost 15 ± 7 (2 - 36) kg. The mean weight on hospital admission (data available for 88 patients; 10 patients were outpatients; missing data, n = 5) was 41.1 ± 6.1 kg.

Description

Patient Inclusion Criteria:

  • diagnosis of anorexia nervosa (DSM-IV)
  • aged 12 - 19 years
  • female gender

Patient Exclusion Criteria:

- existence of a further disease with effect on body composition

Controls:

  • no known disease
  • normal weight

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Inpatient treatment for Anorexia nervosa

Adolescents with anorexia nervosa assessed

  1. at baseline: on admission to inpatient treatment
  2. at follow-up: 6 months after admission on outpatient basis
Nutritional rehabilitation in a clinic with specialized eating disorder service
Controls
Adolescent healthy and normal weight controls (matched for gender and age), assessed at one point of time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Total Body protein
Time Frame: Between baseline (inpatient admission) and at 7 months follow-up
Change in Total Body protein
Between baseline (inpatient admission) and at 7 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body weight
Time Frame: Between baseline (inpatient admission) and at 7 months follow-up
Change in: body weight (kg)
Between baseline (inpatient admission) and at 7 months follow-up
Change in Body Mass Index
Time Frame: Between baseline (inpatient admission) and at 7 months follow-up
Change in Body Mass Index (BMI; kg/m2)
Between baseline (inpatient admission) and at 7 months follow-up
Change in body fat mass
Time Frame: Between baseline (inpatient admission) and at 7 months follow-up
Change in body fat mass (kg)
Between baseline (inpatient admission) and at 7 months follow-up
Change in body lean tissue mass
Time Frame: Between baseline (inpatient admission) and at 7 months follow-up
Change in body lean tissue mass (kg)
Between baseline (inpatient admission) and at 7 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Michael R Kohn, Prof., University of Sydney

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2004

Primary Completion (Actual)

July 1, 2010

Study Completion (Actual)

July 1, 2010

Study Registration Dates

First Submitted

October 29, 2017

First Submitted That Met QC Criteria

November 2, 2017

First Posted (Actual)

November 7, 2017

Study Record Updates

Last Update Posted (Actual)

November 7, 2017

Last Update Submitted That Met QC Criteria

November 2, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Inpatient treatment for Anorexia nervosa

3
Subscribe